None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: From August 01, 2016 to July 31, 2019, patients who visited Department of Cardiology and Neurology, Kyung Hee University Korean Medicine Hospital and were treated (both outpatients and hospitalized patients) with Majain-Hwan (MH). At the same time, the following conditions will be included. • Patients (19 years older) who were diagnosed with Parkinson's disease (G20) or Parkinsonism (G22), based on the results of brain imaging (Brain CT or MR) and clinical symptoms and suffered from constipation (defecation once 3 days or more). • Patients who were prescribed and took MH (code: HH387) to control constipation. • Patients who can confirm the change in constipation via medical records.
Exclusion criteria
Exclusion criteria: The following conditions will be excluded. • Those who have undergone additional medical treatment more than once, but have insufficient medical records to investigate changes in constipation symptoms
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in the number of defecation before and after Mazain-Hwan (MH) treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| Effectiveness of Mazain-Hwan (MH) against constipation of patients with Parkinson's disease and Pakrinsonism | — |
Countries
Korea, Republic of
Contacts
Kyung Hee University Oriental Medical Center